Allied Market Research published a report, titled, “Next Generation Sequencing (NGS) Market by Product (Consumables, Platforms and Services), By Application (Diagnostics, Biomarkers and Cancer, Reproductive Health), Technology (Sequencing by Synthesis, Ion Semiconductor Sequencing, Sequencing by Ligation, Pyrosequencing, Single Molecule Real Time Sequencing, Other Technologies) – Global Opportunity Analysis and Industry Forecast, 2014-2022.” The report offers information on the drivers, restraints, & opportunities, top investment pockets, market segments, market size & share, and the competitive landscape. These insights are helpful for market players, investors, stakeholders, and new entrants to gain major market share and international presence. According to the report, the global next generation sequencing market garnered $3,567 million in 2015 and is projected to accrue a sum of $12,801 million by 2022, growing at a CAGR of 19.9% from 2014 to 2022.
Get Sample Report: https://www.alliedmarketresearch.com/request-sample/2048
The report elaborately analyzes the drivers, restraints, and opportunities of the market. Factors such as surge in NGS applications, rise in technological advancements in NGS, the growth in number of genome mapping programs throughout the world, and increase in R&D investment drive the growth of the market. However, standardization concerns over NGS based diagnostics, lack of skilled professionals, and ethical and legal limitations hinder the growth of the market. Conversely, the utilization of cloud computing in NGS for data management and untapped emerging economies offer significant growth opportunities to the market players.
The report provides an elaborate analysis of the various segments of the NGS market. The market is classified into product, application, technology, and geography. Based on product, the study is bifurcated into consumables, platforms and services. Based on application, the market is divided into diagnostics, biomarkers and cancer, reproductive health. The biomarkers and cancer segment is expected to grow at a CAGR of 19.8% during the forecast period. The technology segment is bifurcated into sequencing by synthesis, ion semiconductor sequencing, sequencing by ligation, pyrosequencing, single molecule real time sequencing, and other technologies. Sequencing by synthesis technology is anticipated to dominate the global market. Regionally, the market analysis covers North America, Europe, Asia-Pacific, and LAMEA.
A broad analysis of the players operating in the NGS market is also offered in the study. Details such as their overview, their business segments under operation, key strategic moves and developments, and more are discussed. The companies profiled in the report include Illumina, Inc., Thermo Fisher Scientific, Inc., Pacific Biosciences of California, Inc., Beijing Genomics Institute, Qiagen N.V., 454 Life Sciences Corporation (Roche Holding AG), Agilent Technologies, Inc., Perkinelmer, Inc., Genomatix GmbH, and PierianDx.